Please ensure Javascript is enabled for purposes of website accessibility
Skip to main content
Focused on muscle and
positioned for growth

SEC Filing

SEC Filing Details

Document Details

Filing Date
Jan 4, 2024
Document Date
Jan 4, 2024
Form Description
Registration of up to an additional 20% of securities for any offering registered on a S-3
Filing Group
Registration Statements
Company
Dyne Therapeutics, Inc.
Issuer
DYNE THERAPEUTICS, INC.